Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Advanced Melanoma Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for advanced melanoma has seen a significant boost in recent times. Its growth is projected to increase from $3.77 billion in 2024 to $4.12 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. The previous growth can be traced back to the authorization of dacarbazine, the progression of interferon therapy, the inception of ipilimumab, incorporation of radiation therapy, arrival of combination therapies, endorsement of nivolumab and the roll-out of pembrolizumab.
In the coming years, the market size of advanced melanoma is expected to witness robust growth, poised to reach $5.85 billion by 2029; this escalates at a compound annual growth rate (CAGR) of 9.2%. The anticipated expansion in the market over the projected period may be credited to advancements in unique checkpoint inhibitors, the growing prominence of personalized medicine, strides in adoptive cell therapy, the rising application of combination therapies, the emergence of bispecific antibodies, the widening of oncolytic virotherapy and an increased emphasis on early detection tools. Forecasts for the period also communicate notable trends such as AI-powered diagnostic tools, mRNA-based cancer vaccines, CRISPR-oriented gene editing, oncolytic virus engineering, liquid biopsy technologies, wearable devices to monitor health, advanced imaging techniques, 3D bioprinting for research, the modeling of tumor microenvironments, and nanoparticle-engaged drug delivery systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21088&type=smp
What External and Internal Drivers Are Contributing to the Growth of theAdvanced Melanoma Market?
The advanced melanoma market is forecasted to grow due to an increase in severe sunburn cases. Severe sunburns are the result of extreme exposure to ultraviolet (UV) radiation, causing redness, pain, swelling, and occasional blistering of the skin. Factors contributing to the rise in severe sunburn cases include extended exposure to UV radiation, inadequate sun safety precautions, increased outdoor activities during high UV times, and rising temperatures due to climate change. DNA damage in skin cells caused by severe, repeated sunburns or by sunburn at a young age can lead to genetic mutations that trigger melanoma. As reported by Melanoma Focus, a UK charity assisting the melanoma community, in May 2024, in the year 2022-23, sunburn resulted in 201 hospital admissions, including 89 children and 25 infants younger than one year. Additionally, 66% of UK adults between the ages of 16 and 65 recollected experiencing sunburn in their childhood, with 65% having severe sunburn accompanied by blisters at least once. This figure rose to 77% for individuals with fair, pale, or white skin. Hence, the rise in severe sunburn cases is boosting the expansion of the advanced melanoma market.
What Segment Types Define the Advanced Melanoma Market Structure?
The advanced melanomamarket covered in this report is segmented –
1) By Therapeutics: Chemotherapy; Biological Therapy; Targeted Therapy; Immune Therapy
2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
3) By End-User: Hospitals; Cancer Research Centres; Academic Institutes; Diagnostic Centers; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Chemotherapy: Alkylating Agents; Antimetabolites; Topoisomerase Inhibitors; Other Chemotherapy Drugs
2) By Biological Therapy: Monoclonal Antibodies; Interferons; Interleukins
3) By Targeted Therapy: BRAF Inhibitors; MEK Inhibitors; KIT Inhibitors; Other Targeted Therapies
4) By Immune Therapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Oncolytic Virus Therapy; Adoptive Cell Transfer
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21088&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Advanced Melanoma Market?
North America was the largest region in the advanced melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Advanced Melanoma Market?
Leading firms in the advanced melanoma market are concentrating on creating novel products such as customized vaccines to enhance treatment effectiveness, combat resistance mechanisms, and offer tailored treatment approaches that could result in improved patient results and extended survival. A custom-made vaccine for advanced melanoma is a cancer therapy specifically tailored to a particular patient, based on the specific genetic mutations in their tumor. For instance, in April 2023, Merck & Co. Inc., a pharmaceutical corporation based in the United States, and Moderna Inc., a US-based biotech firm, were granted Priority Medicines (PRIME) scheme designation by the European Medicines Agency (EMA) for their experimental personalized mRNA cancer vaccine, mRNA-4157/V940, to be used along with Merck’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab) for the adjuvant treatment of patients with high-risk stage III/IV melanoma following successful resection. The specialized cancer vaccine, mRNA-4157/V940, includes a singular synthetic mRNA encoding up to 34 neoantigens and is designed and manufactured according to the distinct mutational signature of the patient’s tumor.
View the full report here:
https://www.thebusinessresearchcompany.com/report/advanced-melanoma-global-market-report
What Is the Definition of the Advanced Melanoma Market?
Advanced melanoma refers to melanoma skin cancer that has spread beyond the original site to other parts of the body. It includes stage III (spread to nearby lymph nodes) and stage IV (metastasized to distant organs l), which is more challenging to treat and often requires a combination of therapies, such as immunotherapy, targeted therapy, chemotherapy, or radiation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21088
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model